Clinical

Treatment options for COVID-19: Dr. Annie Luetkemeyer


 

Annie Luetkemeyer, MD, professor of infectious diseases at UCSF, is an expert on the treatment of viral infections. Robert Wachter, MD, MHM, chair of the UCSF Department of Medicine, interviewed her about the evidence behind potential treatments for COVID-19 (including chloroquine/hydroxychloroquine, remdesivir, and others), as well as how to assess new and existing drugs in a pandemic.

Recommended Reading

Hand washing and hand sanitizer on the skin and COVID-19 infection risk
The Hospitalist
AMA offers resources for front-line physicians
The Hospitalist
CDC coronavirus testing decision likely to haunt nation for months to come
The Hospitalist
High rate of asymptomatic COVID-19 seen in cruise ship passengers
The Hospitalist
Reports increasingly suggest anosmia/hyposmia can signal early COVID-19 infection
The Hospitalist
Three COVID-19 rapid diagnostic tests get FDA thumbs-up
The Hospitalist
COVID-19 critical care guideline offers support for frontline clinicians
The Hospitalist
FDA issues warning on fecal transplant transmission of SARS-CoV-2
The Hospitalist
FDA to allow alternative respiratory devices to treat COVID-19
The Hospitalist
Week-old COVID-19 urology guidelines already outdated
The Hospitalist
   Comments ()